HealthTech · Platform10 weeks · 2025

MediSync: HIPAA-Ready Care Platform on Kubernetes

Zero-trust Kubernetes landing zone with encrypted everything — audit-ready in 10 weeks, deploy time cut from days to minutes.

Cloud InfrastructureDevOpsBackend EngineeringAWSKubernetesTerraform
XLinkedIn
10 wks
To audit-ready

HIPAA controls mapped

-92%
Deploy time

2 days → 11 min

100%
Encrypted surfaces

at-rest + in-transit

0
Critical findings

external pen-test

01 — Challenge

Where it hurt

MediSync coordinated care across clinics on click-ops infrastructure — shared credentials, unencrypted snapshots, and deploys that needed a hero. A hospital partnership required HIPAA controls they could prove, not promise.

02 — Approach

What we built

We built a multi-account landing zone with private EKS clusters, IRSA-scoped service identities, Secrets Manager via Vault, and GitOps promotion with signed artifacts. Every control maps to a Terraform module and a Config rule — evidence generated by the pipeline, not assembled before the audit.

Outcomes, with receipts

  • HIPAA control matrix with per-control Terraform evidence and audit logs
  • Private EKS with zero-trust network policies and mTLS service mesh
  • ArgoCD promotion: preview → staging → prod with signed images only
  • On-call with SLO burn alerts — 3 pages in 6 months, all actionable

Healthcare partnerships die on security questionnaires. MediSync needed controls that were real before they were documented — encryption, identity, and delivery discipline provable from the infrastructure itself.

Zero-trust from day one

No shared credentials, no public nodes, no long-lived keys. Workloads assume IAM roles via IRSA, operators authenticate with SSO + hardware keys, and every secret rotates on schedule. Network policies default-deny; each allowance is a reviewed YAML file, not a console click.

Evidence as a build artifact

Config rules, CloudTrail aggregation, and signed SBOMs flow into an evidence bucket per environment. The audit packet is generated, not gathered — which is why the external pen-test returned zero criticals and the partnership closed two weeks early.

“The auditors asked for evidence and we sent pipeline links. That has never happened before.”

Dr. Samuel Adeyemi — Founder, MediSync